Сердечная недостаточность и ожирение
- Авторы: Сафиуллина А.А.1, Ускач Т.М.1,2, Сайпудинова К.М.1, Терещенко С.Н.1,2, Чазова И.Е.1
-
Учреждения:
- ФГБУ «Национальный медицинский исследовательский центр кардиологии им. акад. Е.И. Чазова» Минздрава России
- ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
- Выпуск: Том 94, № 9 (2022)
- Страницы: 1115-1121
- Раздел: Обзоры
- URL: https://journals.rcsi.science/0040-3660/article/view/83125
- DOI: https://doi.org/10.26442/00403660.2022.09.201837
- ID: 83125
Цитировать
Полный текст
Аннотация
Ожирение является независимым предиктором сердечно-сосудистых заболеваний (ССЗ), в том числе сердечной недостаточности (СН). Тем не менее многочисленные исследования показали, что пациенты с ССЗ, имеющие избыточную массу тела и легкую стадию ожирения, имеют лучший краткосрочный и умеренный прогноз, чем более худые пациенты с ССЗ. Данный феномен назвали «парадоксом ожирения». Понимание «парадокса ожирения» имеет важное значение у пациентов с СН, учитывая высокую распространенность ожирения среди них. В статье представлен обзор клинических исследований, посвященных изучению ожирения как фактора риска СН, патогенеза СН при ожирении, освещены вопросы «парадокса ожирения» и лечения ожирения у данной категории пациентов.
Ключевые слова
Полный текст
Открыть статью на сайте журналаОб авторах
Альфия Ахатовна Сафиуллина
ФГБУ «Национальный медицинский исследовательский центр кардиологии им. акад. Е.И. Чазова» Минздрава России
Автор, ответственный за переписку.
Email: a_safiulina@mail.ru
ORCID iD: 0000-0003-3483-4698
канд. мед. наук, науч. сотр. отд. заболеваний миокарда и сердечной недостаточности
Россия, МоскваТатьяна Марковна Ускач
ФГБУ «Национальный медицинский исследовательский центр кардиологии им. акад. Е.И. Чазова» Минздрава России; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Email: a_safiulina@mail.ru
ORCID iD: 0000-0003-4318-0315
д-р мед. наук, вед. науч. сотр. отд. заболеваний миокарда и сердечной недостаточности; проф. каф. кардиологии
Россия, Москва; МоскваКарина Магомедовна Сайпудинова
ФГБУ «Национальный медицинский исследовательский центр кардиологии им. акад. Е.И. Чазова» Минздрава России
Email: a_safiulina@mail.ru
ORCID iD: 0000-0002-3757-1160
врач-аспирант отд. заболеваний миокарда и сердечной недостаточности
Россия, МоскваСергей Николаевич Терещенко
ФГБУ «Национальный медицинский исследовательский центр кардиологии им. акад. Е.И. Чазова» Минздрава России; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Email: a_safiulina@mail.ru
ORCID iD: 0000-0001-9234-6129
д-р мед. наук, проф., рук. отд. заболеваний миокарда и сердечной недостаточности; зав. каф. кардиологии
Россия, Москва; МоскваИрина Евгеньевна Чазова
ФГБУ «Национальный медицинский исследовательский центр кардиологии им. акад. Е.И. Чазова» Минздрава России
Email: a_safiulina@mail.ru
ORCID iD: 0000-0002-9822-4357
акад. РАН, д-р мед. наук, проф., зам. ген. дир. по научно-экспертной работе, рук. отд. гипертонии
Россия, МоскваСписок литературы
- NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377-96. doi: 10.1016/S0140-6736(16)30054-X
- Муромцева Г.А., Концевая А.В., Константинов В.В., и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012–2013 гг. Результаты исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2014;13(6):4-11 [Muromtseva GA, Kontsevaya AV, Konstantinov VV, et al. The prevalence of noninfectious diseases risk factors in Russian population in 2012–2013 years. The results of ECVD-RF. Cardiovascular Therapy and Prevention. 2014;13(6):4-11 (in Russian)]. doi: 10.15829/1728-8800-2014-6-4-11
- Lavie CJ, Arena R, Alpert MA, et al. Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol. 2018;15:45-56.
- Lavie CJ, Sharma A, Alpert MA, et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis. 2016;58:393-400.
- McDonagh TA, Metra M, Adamo M, et al; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. doi: 10.1093/eurheartj/ehab368
- Ross R, Blair SN, Arena R, et al. Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement from the American Heart Association. Circulation. 2016;134:e653-99. doi: 10.1161/CIR.0000000000000461
- Del Buono MG, Arena R, Borlaug BA, et al. Exercise Intolerance in Patients with Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73:2209-25. doi: 10.1016/j.jacc.2019.01.072
- Mandsager K, Harb S, Cremer P, et al. Association of Cardiorespiratory Fitness with Long-term Mortality Among Adults Undergoing Exercise Treadmill Test-ing. JAMA Netw Open. 2018;1(6):e183605. doi: 10.1001/jamanetworkopen.2018.3605
- Kondamudi N, Haykowsky M, Forman DE, et al. Exercise Training for Prevention and Treatment of Heart Failure. Prog Cardiovasc Dis. 2017;60:115-20. doi: 10.1016/j.pcad.2017.07.001
- Pandey A, Garg S, Khunger M, et al. Dose-response relationship between physical activity and risk of heart failure: a meta-analysis. Circulation. 2015;132(19):1786-94.
- Pandey A, Patel M, Gao A, et al. Changes in midlife fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal Study. Am Heart J. 2015;169(2):290-7.
- Bhaskaran K, Dos-Santos-Silva I, Leon DA, et al. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6:944-53. doi: 10.1016/S2213-8587(18)30288-2
- Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305-13. doi: 10.1056/NEJMoa020245
- Savji N, Meijers WC, Bartz TM, et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail. 2018;6:701-9. doi: 10.1016/j.jchf.2018.05.018
- Liu L, Lima JAC, Post WS, et al. Associations of time-varying obesity and metabolic syndrome with risk of incident heart failure and its subtypes: Findings from the Multi-Ethnic Study of Atherosclerosis. Int J Cardiol. 2021;338:127-35. doi: 10.1016/j.ijcard.2021.05.051
- Bi J, Song L, Wang L, et al. Transitions in metabolic health status over time and risk of heart failure: a prospective study. Diabetes Metab. 2021;48(1):101266. doi: 10.1016/j.diabet.2021.101266
- Fauchier G, Bisson A, Bodin A, et al. Metabolically healthy obesity and cardiovascular events: A nationwide cohort study. Diabetes Obes Metab. 2021;23(11):2492-501. doi: 10.1111/dom.14492
- Zhou Z, Macpherson J, Gray SR, et al. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants. Diabetologia. 2021;64(9):1963-72. doi: 10.1007/s00125-021-05484-6
- Tian S, Xu Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr Gerontol Int. 2016;16:155-66. doi: 10.1111/ggi.12579
- Sharma A, Lavie CJ, Borer JS, et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015;115:1428-34. doi: 10.1016/j.amjcard.2015.02.024
- Chandramouli C, Tay WT, Bamadhaj NS, et al. Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study. PLoS Med. 2019;16:1-17. doi: 10.1371/journal.pmed.1002916
- Amato MC, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Invest. 2013;36:537-43. doi: 10.3275/8943
- Rotella CM, Dicembrini I. Measurement of body composition as a surrogate evaluation of energy balance in obese patients. World J Methodol. 2015;5:1-9. doi: 10.5662/wjm.v5.i1.1
- Rao VN, Zhao D, Allison MA, et al. Adiposity and incident heart failure and its subtypes MESA (multi-ethnic study of atherosclerosis). JACC Heart Fail. 2018;6:999-1007. doi: 10.1016/j.jchf.2018.07.009
- Pandey A, Kondamudi N, Patel KV, et al. Association between regional adipose tissue distribution and risk of heart failure among blacks. Circ Heart Fail. 2018;11:e005629. doi: 10.1161/CIRCHEARTFAILURE.118.005629
- Nicklas BJ, Cesari M, Penninx BWJH, et al. Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc. 2006;54:413-20. doi: 10.1111/j.1532-5415.2005.00624.x
- Carbone S, Billingsley HE, Rodriguez-Miguelez P, et al. Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia. Curr Probl Cardiol. 2020;45:100417. doi: 10.1016/j.cpcardiol.2019.03.006
- De Schutter A, Lavie CJ, Kachur S, et al. Body composition and mortality in a large cohort with preserved ejection fraction: Untangling the obesity paradox. Mayo Clin Proc. 2014;89:1072-9. doi: 10.1016/j.mayocp.2014.04.025
- Kitzman DW, Brubaker P, Morgan T, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2016;315:36-46. doi: 10.1001/jama.2015.17346
- Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis. 2014;56:391-400.
- Alpert MA, Lavie CJ, Agrawal H, et al. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations and management. Transl Res. 2014;164:345-56.
- Sung JK, Kim JY. Obesity and preclinical changes of cardiac geometry and function. Korean Circ J. 2010;40(2):55-61. doi: 10.4070/kcj.2010.40.2.55
- Aurigemma GP, de Simone G, Fitzgibbons TP. Cardiac remodeling in obesity. Circ Cardiovasc Imaging. 2013;6(1):142-52. doi: 10.1161/CIRCIMAGING.111.964627
- Woodwiss AJ, Libhaber CD, Majane OH, et al. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens. 2008;21:1144-51.
- Tumuklu MM, Etikan I, Kisacik B, Kayikcioglu M. Effect of obesity on left ventricular structure and myocardial systolic function: assessment by tissue Doppler imaging and strain/strain rate imaging. Echocardiography. 2007;24(8):802-9. doi: 10.1111/j.1540-8175.2007.00484.x
- Wang YC, Liang CS, Gopal DM, et al. Preclinical systolic and diastolic dysfunctions in metabolically healthy and unhealthy obese individuals. Circ Heart Fail. 2015;8(5):897-904. doi: 10.1161/CIRCHEARTFAILURE.114.002026
- Russo C, Sera F, Jin Z, et al. Abdominal adiposity, general obesity, and subclinical systolic dysfunction in the elderly: a population-based cohort study. Eur J Heart Fail. 2016;18(5):537-44. doi: 10.1002/ejhf.521
- Garg PK, Biggs ML, Kizer JR, et al. Associations of body size and composition with subclinical cardiac dysfunction in older individuals: the cardiovascular health study. Int J Obes (Lond). 2021;45(12):2539-45. doi: 10.1038/s41366-021-00926-y
- Blomstrand P, Sjöblom P, Nilsson M, et al. Overweight and obesity impair left ventricular systolic function as measured by left ventricular ejection fraction and global longitudinal strain. Cardiovasc Diabetol. 2018;17(1):113. doi: 10.1186/s12933-018-0756-2
- Ren J, Wu NN, Wang S, et al. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101(4):1745-807. doi: 10.1152/physrev.00030.2020
- Carbone S, Javie CJ, Elagizi A, et al. The Impact of Obesity in Heart Failure. Heart Fail Clin. 2020;16(1):71-80. doi: 10.1016/j.hfc.2019.08.008
- Peterson LR. Obesity and insulin resistance: effects on cardiac structure, function and substrate metabolism. Curr Hypertension Rep. 2006;8:451-6.
- Gruson D, Ahn SA, Rosseau MF. Biomarkers of inflammation and cardiac remodeling: the quest of relevant companions for the risk stratification of heart failure patients is still on going. Biochem Med (Zagreb). 2011;21:254-63. doi: 10.11613/BM.2011.035
- Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38(3):789-95. doi: 10.1016/s0735-1097(01)01448-6
- Kapoor JR, Heidenreich PA. Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J. 2010;159(1):75-80. doi: 10.1016/j.ahj.2009.10.026
- Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156(1):13-22. doi: 10.1016/j.ahj.2008.02.014
- Zamora E, Lupon J, Urrutia A, et al. Does body mass index influence mortality in patients with heart failure? Rev Esp Cardiol. 2007;60(11):1127-34 (in Spanish).
- Curtis JP, Soko SI, Wang Y, et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol. 2003;42(4):736-42. doi: 10.1016/s0735-1097(03)00789-7
- Fonarow GC, Srikanthan P, Costanzo MR, et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007;153(1):74-81.
- Haass M, Kitzman DW, Anand IS, et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Heart Fail. 2011;4:324-31. doi: 10.1161/CIRCHEARTFAILURE.110.959890
- Kenchaiah S, Pocock SJ, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation. 2007;116:627-36. doi: 10.1161/CIRCULATIONAHA.106.679779
- Hegde SM, Claggett B, Shah AM, et al. Physical activity and prognosis in the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist). Circulation. 2017;136(11):982-92. doi: 10.1161/CIRCULATIONAHA.117.028002
- Carbone S, Canada JM, Billingsley HE, et al. Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag. 2019;15:89-100. doi: 10.2147/VHRM.S168946
- Carbone S, Lavie CJ, Arena R. Obesity and heart failure: focus on the obesity paradox. Mayo Clinic Proc. 2017;92:266-79. doi: 10.1016/j.mayocp.2016.11.001
- Itoh H, Kaneko H, Kiriyama H, et al. Reverse J-shaped relationship between body mass index and in-hospital mortality of patients hospitalized for heart failure in Japan. Heart Vessels. 2021;36(3):383-92. doi: 10.1007/s00380-020-01699-6
- Padwal R, McAlister F, McMurray J, et al; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond). 2014;38(8):1110-4. doi: 10.1038/ijo.2013.203
- Wang L, Zhao LP, Chen Y, et al. Obesity paradox in pulmonary hypertension due to left ventricular systolic dysfunction. Herz. 2021;46(6):575-80. doi: 10.1007/s00059-021-05023-4
- Piepoli MF, Corra U, Veglia F, et al; MECKI Score Research Group. Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group. Eur J Heart Fail. 2016;18(5):545-53. doi: 10.1002/ejhf.534
- Lavie CJ, Alpert MA, Arena R, et al. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013;1(2):98-102. doi: 10.1016/j.jchf.2013.01.006
- Дедов И.И., Мельниченко Г.А., Шестакова М.В., и др. Национальные клинические рекомендации по лечению морбидного ожирения у взрослых. 3-ий пересмотр (лечение морбидного ожирения у взрослых). Ожирение и метаболизм. 2018;15(1):53-70 [Dedov II, Mel'nichenko GA, Shestakova MV, et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults). Obesity and Metabolism. 2018;15(1):53-70 (in Russian)]. doi: 10.14341/OMET2018153-70
- Flynn KE, Piña IL, Whellan DJ, et al; HF-ACTION Investigators. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1451-9. doi: 10.1001/jama.2009.457
- Jorsal A, Kistorp C, Holmager P, et al. Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE): a multicentre, double-blind, randomised, placebo-controlled trial. Eur J Heart Fail. 2017;19:69-77. doi: 10.1002/ejhf
- Adamson C, Jhund PS, Docherty KF, et al. Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. Eur J Heart Fail. 2021;23(10):1662-72. doi: 10.1002/ejhf.2308
- Oyama K, Raz I, Cahn A, et al. Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes melli-tus in the DECLARE-TIMI 58 trial. Eur Heart J. 2022;43(31):2958-67. doi: 10.1093/eurheartj/ehab530
- Bozkurt B, Aguilar D, Deswal A, et al. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134:e535-78. doi: 10.1161/CIR.0000000000000450
- Lavie CJ, Laddu D, Arena R, et al. Reprint of: healthy weight and obesity prevention: JACC Health Promotion Series. J Am Coll Cardiol. 2018;72(Pt. B):3027-52. doi: 10.1016/j.jacc.2018.10.024
- Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61:151-6. doi: 10.1016/j.pcad.2018.05.005
- Sundstrom J, Bruze G, Ottosson J, et al. Weight loss and heart failure: a nationwide study of gastric bypass surgery versus intensive lifestyle treatment. Circulation. 2017;135(17):1577-85. doi: 10.1161/CIRCULATIONAHA.116.025629
- Shimada YJ, Tsugawa Y, Brown DFM, Hasegawa K. Bariatric surgery and emergency department visits and hospitalizations for heart failure exacerbation: population-based, self-controlled series. J Am Coll Cardiol. 2016;67(8):895-903. doi: 10.1016/j.jacc.2015.12.016